InterOcean Capital Group’s Novartis NVS Stock Holding History

InterOcean Capital Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$325K	Hold	3,357	–	–	0.01%	377
2023 Q4	$339K	Buy	3,357 +38	+1%	+$3.67K	0.01%	355
2023 Q3	$338K	Buy	3,319 +4	+0.1%	+$406	0.01%	323
2023 Q2	$335K	Buy	3,315 +58	+2%	+$5.8K	0.01%	340
2023 Q1	$300K	Hold	3,257	–	–	0.01%	319
2022 Q4	$295K	Sell	3,257 -157	-5%	-$13.2K	0.01%	332
2022 Q3	$259K	Sell	3,414 -624	-15%	-$51.7K	0.01%	335
2022 Q2	$341K	Buy	+4,038	New	+$354K	0.01%	302

Other funds holding NVS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

InterOcean Capital Group's NVS Position: Q1 2024 in Review

InterOcean Capital Group held its Novartis (NVS) position steady in Q1 2024 at 3,357 shares worth $325K. The position accounts for 0.01% of the portfolio, ranked #377.

InterOcean Capital Group first reported a position in NVS in Q2 2022 and has held it in 8 quarters since. The position peaked at $341K in Q2 2022. 1,254 funds tracked by Wall St. Rank hold NVS as of Q1 2024.

InterOcean Capital Group held 3,357 shares of Novartis worth $325K as of Q1 2024.
InterOcean Capital Group left its Novartis share count unchanged in Q1 2024.
Novartis made up 0.01% of InterOcean Capital Group's portfolio in Q1 2024, its #377 holding.
InterOcean Capital Group first reported a position in Novartis in Q2 2022 and has held it in 8 quarters since.
InterOcean Capital Group's Novartis position peaked at $341K in Q2 2022.
1,254 funds tracked by Wall St. Rank held Novartis as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.